Skip to main content

New Target and Drug Candidates for Alleviating Chronic Pain

Project description

Insensitive mice may elucidate a path to relief for chronic pain

Estimates suggest that at least one in five people globally suffer from chronic pain. Aside from impairing a person's ability to perform activities of daily living, chronic pain can lead to a chronic stress reaction. This can increase blood pressure and heart rate and result in other harmful effects on health including reduced immunity to illnesses and diseases. Knockdown of a specific gene in mice leads to reduced sensitivity to pain, and researchers have now identified several existing drugs that could mimic this effect. EU funding of the ChronicPain project is helping these researchers exploit their discovery, using it to test approved and candidate drugs on the path to relief for millions of people suffering with chronic pain.

Host institution

WEIZMANN INSTITUTE OF SCIENCE
Net EU contribution
€ 150 000,00
Address
Herzl Street 234
7610001 Rehovot
Israel

See on map

Activity type
Higher or Secondary Education Establishments
Other funding
No data

Beneficiaries (1)

WEIZMANN INSTITUTE OF SCIENCE
Israel
Net EU contribution
€ 150 000,00
Address
Herzl Street 234
7610001 Rehovot

See on map

Activity type
Higher or Secondary Education Establishments
Other funding
No data